Eckert & Ziegler Strahlen und Medizintechnik (EUZ) Stock Statistics & Valuation Metrics

Eckert & Ziegler Strahlen und Medizintechnik has a market cap or net worth of CHF 766.70M. The enterprise value is CHF 892.81M.

Market Cap

CHF 766.70M

Enterprise Value

CHF 892.81M

Eckert & Ziegler Strahlen und Medizintechnik has 63,515,797 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

63,515,797

Owned by Insiders

―

Owned by Institutions

8.45%

Eckert & Ziegler Strahlen und Medizintechnik’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 11.99%.

Return on Equity (ROE)

0.19

Return on Assets (ROA)

0.10

Return on Invested Capital (ROIC)

11.99%

Return on Capital Employed (ROCE)

0.18

Revenue Per Employee

282.32K

Profits Per Employee

44.13K

Employee Count

1,105

Asset Turnover

0.64

Inventory Turnover

3.58

The current PE Ratio of Eckert & Ziegler Strahlen und Medizintechnik is 16.63. Eckert & Ziegler Strahlen und Medizintechnik’s PEG ratio is 0.26.

PE Ratio

16.63

PS Ratio

2.66

PB Ratio

3.11

Price to FCF

31.90

Price to Operating Cash Flow

16.22

PEG Ratio

0.26

In the last 12 months, Eckert & Ziegler Strahlen und Medizintechnik had revenue of 311.96M and earned 48.76M in profits. Earnings per share was 0.78.

Revenue

311.96M

Gross Profit

147.21M

Operating Income

75.06M

Pretax Income

72.77M

Net Income

48.76M

EBITDA

92.13M

Earnings Per Share (EPS)

0.78

In the last 12 months, operating cash flow was 51.61M and capital expenditures -25.52M, giving a free cash flow of 26.09M billion.

Operating Cash Flow

51.61M

Free Cash Flow

26.09M

Free Cash Flow per Share

0.41

Eckert & Ziegler Strahlen und Medizintechnik pays an annual dividend of ―, resulting in a dividend yield of 1.77%

Dividend Per Share

―

Dividend Yield

1.77%

Payout Ratio

N/A

Free Cash Flow Yield

3.13%

Earnings Yield

5.94%

Beta

0.90

52-Week Price Change

-9.37%

50-Day Moving Average

12.03

200-Day Moving Average

12.30

Relative Strength Index (RSI)

3.86

Average Volume (3m)

859

Eckert & Ziegler Strahlen und Medizintechnik upcoming earnings date is Nov 12, 2026, Before Open (Not Confirmed).

Last Earnings Date

Aug 13, 2026

Next Earnings Date

Nov 12, 2026

Ex-Dividend Date

―

Eckert & Ziegler Strahlen und Medizintechnik as a current ratio of 3.45, with Debt / Equity ratio of 17.80%

Current Ratio

3.45

Quick Ratio

2.81

Debt to Market Cap

0.01

Net Debt to EBITDA

-0.91

Interest Coverage Ratio

38.67

In the past 12 months, Eckert & Ziegler Strahlen und Medizintechnik has paid 23.54M in taxes.

Income Tax

23.54M

Effective Tax Rate

0.32

Eckert & Ziegler Strahlen und Medizintechnik EV to EBITDA ratio is 8.19, with an EV/FCF ratio of 29.25.

EV to Sales

2.44

EV to EBITDA

8.19

EV to Free Cash Flow

29.25

EV to Operating Cash Flow

14.79

Eckert & Ziegler Strahlen und Medizintechnik has CHF 110.33M in cash and marketable securities with CHF 41.04M in debt, giving a net cash position of CHF 69.29M billion.

Cash & Marketable Securities

CHF 110.33M

Total Debt

CHF 41.04M

Net Cash

CHF 69.29M

Net Cash Per Share

CHF 1.09

Tangible Book Value Per Share

CHF 3.55

Gross margin is 46.87%, with operating margin of 24.09%, and net profit margin of 15.91%.

Gross Margin

46.87%

Operating Margin

24.09%

Pretax Margin

23.31%

Net Profit Margin

15.91%

EBITDA Margin

29.82%

EBIT Margin

24.32%

The average price target for Eckert & Ziegler Strahlen und Medizintechnik is CHF 20.22, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

CHF 20.22

Price Target Upside

74.86% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

2.56%

EPS Growth Forecast

33.38%

Smart Score

6

AI Score

―